chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Fatigue, Nasal congestion, Rhinorrhoea, Sneezing
Clinical narrative: Congested nose; Developed a Sneezing episode; When moved head over and water was coming out of my nose; Felt excessively tired and all they wanted to do was lay down; This spontaneous case was reported by a consumer and describes the occurrence of NASAL CONGESTION (Congested nose), RHINORRHOEA (When moved head over and water was coming out of my nose), SNEEZING (Developed a Sneezing episode) and FATIGUE (Felt excessively tired and all they wanted to do was lay down) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     Concurrent medical conditions included Lacunar stroke (Affected their right side) since 01-Dec-2018. Concomitant products included APIXABAN (ELIQUIS) from 01-Dec-2018 to an unknown date for Lacunar stroke.    On 16-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Apr-2021 at 2:00 PM,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced FATIGUE (Felt excessively tired and all they wanted to do was lay down). On 17-Apr-2021, the patient experienced RHINORRHOEA (When moved head over and water was coming out of my nose). On 17-Apr-2021 at 6:00 AM, the patient experienced SNEEZING (Developed a Sneezing episode). On an unknown date, the patient experienced NASAL CONGESTION (Congested nose). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] at an unspecified dose and frequency. On 17-Apr-2021 at 8:30 PM, FATIGUE (Felt excessively tired and all they wanted to do was lay down) had resolved. At the time of the report, NASAL CONGESTION (Congested nose), RHINORRHOEA (When moved head over and water was coming out of my nose) and SNEEZING (Developed a Sneezing episode) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Apr-2021, Body temperature: (Inconclusive) 98.6F. On 02-May-2021, Body temperature: (Low) 94.6F.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-100481, MOD-2021-101106 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash all over the body; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash all over the body) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (Rash all over the body). At the time of the report, RASH (Rash all over the body) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication was not provided. Treatment information was not provided.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Feeling hot, Headache
Clinical narrative: Hotness; Very tired; Headache; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (Hotness), FATIGUE (Very tired) and HEADACHE (Headache) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 009C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Apr-2021, the patient experienced FEELING HOT (Hotness), FATIGUE (Very tired) and HEADACHE (Headache). On 30-Apr-2021, FEELING HOT (Hotness), FATIGUE (Very tired) and HEADACHE (Headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment information was reported.   This case was linked to MOD-2021-101181 (Patient Link).
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Discomfort, Mobility decreased, Pain in extremity, Vaginal haemorrhage
Clinical narrative: abdomen started cramping; woke up with "blood in her panties"; arm hurt real bad; hard to move her hand over her head; could not sleep on the left side; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm hurt real bad), MOBILITY DECREASED (hard to move her hand over her head), DISCOMFORT (could not sleep on the left side), ABDOMINAL PAIN (abdomen started cramping) and VAGINAL HAEMORRHAGE (woke up with "blood in her panties") in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027B21A) for COVID-19 vaccination.     The patient's past medical history included Infertility (The patient was told she is infertile at 38 years.) and Absence of menstruation. Concomitant products included MORPHINE, ESTRADIOL, PROGESTERONE, MODAFINIL, MORPHINE SULFATE, PANTOPRAZOLE, LEVETIRACETAM (KEPPRA XR), ALUMINIUM HYDROXIDE, DICYCLOVERINE HYDROCHLORIDE, MAGNESIUM OXIDUM LEVE (DICYCLOMINE CO), LEVODOPA, CLONAZEPAM, ESCITALOPRAM OXALATE (LEXAPRO), NORTRIPTYLINE, LORAZEPAM, DONEPEZIL, ONDANSETRON and CAFFEINE, CHLORZOXAZONE, PARACETAMOL, THIAMINE DISULFIDE (SOMA [CAFFEINE;CHLORZOXAZONE;PARACETAMOL;THIAMINE DISULFIDE]) for an unknown indication.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced PAIN IN EXTREMITY (arm hurt real bad), MOBILITY DECREASED (hard to move her hand over her head) and DISCOMFORT (could not sleep on the left side). On 02-May-2021, the patient experienced ABDOMINAL PAIN (abdomen started cramping) and VAGINAL HAEMORRHAGE (woke up with "blood in her panties"). On 11-Apr-2021, PAIN IN EXTREMITY (arm hurt real bad) had resolved. At the time of the report, MOBILITY DECREASED (hard to move her hand over her head), DISCOMFORT (could not sleep on the left side), ABDOMINAL PAIN (abdomen started cramping) and VAGINAL HAEMORRHAGE (woke up with "blood in her panties") outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment was administered.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Hypertension, Pain in extremity
Clinical narrative: high blood pressure; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of HYPERTENSION (high blood pressure) and PAIN IN EXTREMITY (sore arm) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043L20A and 030M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 30-Apr-2021, the patient experienced HYPERTENSION (high blood pressure). At the time of the report, HYPERTENSION (high blood pressure) and PAIN IN EXTREMITY (sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was not applicable.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Cough, Dyspnoea, Headache, Myalgia
Clinical narrative: This spontaneous case reported by a consumer (subsequently medically confirmed), describes the occurrence of dyspnea (shortness of breath), cough, pyrexia (fever), headache and chills in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 037A21B) for COVID-19 immunization. The occurrence of additional events detailed below. Concurrent medical conditions included Hashimoto's disease. On Apr 9, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Apr 10, 2021, patient myalgia (muscle aches). The patient treated with albuterol (salbutamol) for cough and shortness of breath, at an unspecified dose and frequency. On Apr 18, 2021, dyspnea (shortness of breath), cough, pyrexia (fever), headache, chills and myalgia (muscle aches) resolved. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. No concomitant medications reported. Lab data included COVID-19 test, flu test and X- ray (in emergency room) with unknown results. Description: The symptoms not related to COVID.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: This spontaneous case reported by a consumer (subsequently medically confirmed), describes the occurrence of dyspnea (shortness of breath), cough, pyrexia (fever), headache and chills in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 037A21B) for COVID-19 immunization. The occurrence of additional events detailed below. Concurrent medical conditions included Hashimoto's disease. On Apr 9, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Apr 10, 2021, patient myalgia (muscle aches). The patient treated with albuterol (salbutamol) for cough and shortness of breath, at an unspecified dose and frequency. On Apr 18, 2021, dyspnea (shortness of breath), cough, pyrexia (fever), headache, chills and myalgia (muscle aches) resolved. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. No concomitant medications reported. Lab data included COVID-19 test, flu test and X- ray (in emergency room) with unknown results. Description: The symptoms not related to COVID.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site swelling
Clinical narrative: Red at injection site; sore injection site; swollen injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Red at injection site), VACCINATION SITE PAIN (sore injection site) and VACCINATION SITE SWELLING (swollen injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (Red at injection site), VACCINATION SITE PAIN (sore injection site) and VACCINATION SITE SWELLING (swollen injection site). At the time of the report, VACCINATION SITE ERYTHEMA (Red at injection site), VACCINATION SITE PAIN (sore injection site) and VACCINATION SITE SWELLING (swollen injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chills, Fatigue, Headache, Insomnia
Clinical narrative: Covid-19; sore throat; little difficulty sleeping; chills; low grade fever; headache; tiredness; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Covid-19), INSOMNIA (little difficulty sleeping), OROPHARYNGEAL PAIN (sore throat), HEADACHE (headache) and FATIGUE (tiredness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, the patient experienced HEADACHE (headache), FATIGUE (tiredness) and PYREXIA (low grade fever). On 08-Apr-2021, the patient experienced INSOMNIA (little difficulty sleeping) and CHILLS (chills). On 10-Apr-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat). On 11-Apr-2021, the patient experienced COVID-19 (Covid-19). On 17-Apr-2021, INSOMNIA (little difficulty sleeping), OROPHARYNGEAL PAIN (sore throat), HEADACHE (headache), CHILLS (chills) and PYREXIA (low grade fever) had resolved. At the time of the report, COVID-19 (Covid-19) and FATIGUE (tiredness) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Apr-2021, COVID-19: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported.Treatment medication was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pyrexia
Clinical narrative: Covid-19; sore throat; little difficulty sleeping; chills; low grade fever; headache; tiredness; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Covid-19), INSOMNIA (little difficulty sleeping), OROPHARYNGEAL PAIN (sore throat), HEADACHE (headache) and FATIGUE (tiredness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, the patient experienced HEADACHE (headache), FATIGUE (tiredness) and PYREXIA (low grade fever). On 08-Apr-2021, the patient experienced INSOMNIA (little difficulty sleeping) and CHILLS (chills). On 10-Apr-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat). On 11-Apr-2021, the patient experienced COVID-19 (Covid-19). On 17-Apr-2021, INSOMNIA (little difficulty sleeping), OROPHARYNGEAL PAIN (sore throat), HEADACHE (headache), CHILLS (chills) and PYREXIA (low grade fever) had resolved. At the time of the report, COVID-19 (Covid-19) and FATIGUE (tiredness) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Apr-2021, COVID-19: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported.Treatment medication was not provided.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Bone pain, Gait disturbance, Herpes zoster, Neuralgia
Clinical narrative: shingles; difficulty walking; foot on and off pain; bone is painful; left pelvic side on and off pain; nerves are painful; rashes on her butt not itchy at all and at the back of her knees as well; knee on and off pain; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HERPES ZOSTER (shingles), GAIT DISTURBANCE (difficulty walking), PAIN IN EXTREMITY (foot on and off pain), BONE PAIN (bone is painful) and PELVIC PAIN (left pelvic side on and off pain) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Gluten sensitivity, Seafood allergy (Allergic to Shrimp ) and Seafood allergy (Allergy to lobster).    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HERPES ZOSTER (shingles), GAIT DISTURBANCE (difficulty walking), PAIN IN EXTREMITY (foot on and off pain), BONE PAIN (bone is painful), PELVIC PAIN (left pelvic side on and off pain), NEURALGIA (nerves are painful), RASH (rashes on her butt not itchy at all and at the back of her knees as well) and ARTHRALGIA (knee on and off pain). The patient was treated with GABAPENTIN at an unspecified dose and frequency and PREDNISONE for Gluten sensitivity, at an unspecified dose and frequency. At the time of the report, HERPES ZOSTER (shingles), GAIT DISTURBANCE (difficulty walking), PAIN IN EXTREMITY (foot on and off pain), BONE PAIN (bone is painful), PELVIC PAIN (left pelvic side on and off pain), NEURALGIA (nerves are painful), RASH (rashes on her butt not itchy at all and at the back of her knees as well) and ARTHRALGIA (knee on and off pain) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Platelet count: good (normal) normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient's pain reportedly 8/10 on the pain scale sometimes and 6/10 most of the time. Patient could only walk on one side and couldn't really work for two weeks. Muscle relaxants did not help and events came back after Gabapentin medication wore off.  Patient underwent blood test (results not provided). Concomitant product use was not provided by the reporter.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pelvic pain, Platelet count, Rash
Clinical narrative: shingles; difficulty walking; foot on and off pain; bone is painful; left pelvic side on and off pain; nerves are painful; rashes on her butt not itchy at all and at the back of her knees as well; knee on and off pain; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HERPES ZOSTER (shingles), GAIT DISTURBANCE (difficulty walking), PAIN IN EXTREMITY (foot on and off pain), BONE PAIN (bone is painful) and PELVIC PAIN (left pelvic side on and off pain) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Gluten sensitivity, Seafood allergy (Allergic to Shrimp ) and Seafood allergy (Allergy to lobster).    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HERPES ZOSTER (shingles), GAIT DISTURBANCE (difficulty walking), PAIN IN EXTREMITY (foot on and off pain), BONE PAIN (bone is painful), PELVIC PAIN (left pelvic side on and off pain), NEURALGIA (nerves are painful), RASH (rashes on her butt not itchy at all and at the back of her knees as well) and ARTHRALGIA (knee on and off pain). The patient was treated with GABAPENTIN at an unspecified dose and frequency and PREDNISONE for Gluten sensitivity, at an unspecified dose and frequency. At the time of the report, HERPES ZOSTER (shingles), GAIT DISTURBANCE (difficulty walking), PAIN IN EXTREMITY (foot on and off pain), BONE PAIN (bone is painful), PELVIC PAIN (left pelvic side on and off pain), NEURALGIA (nerves are painful), RASH (rashes on her butt not itchy at all and at the back of her knees as well) and ARTHRALGIA (knee on and off pain) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Platelet count: good (normal) normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient's pain reportedly 8/10 on the pain scale sometimes and 6/10 most of the time. Patient could only walk on one side and couldn't really work for two weeks. Muscle relaxants did not help and events came back after Gabapentin medication wore off.  Patient underwent blood test (results not provided). Concomitant product use was not provided by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: No second dose after 35 days; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (No second dose after 35 days) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-May-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (No second dose after 35 days). On 01-May-2021, PRODUCT DOSE OMISSION ISSUE (No second dose after 35 days) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.   Treatment information was not provided.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Headache, Maternal exposure during breast feeding, Myalgia
Clinical narrative: Breastfeeding; Dizziness; headache; fatigue; muscle ache; This spontaneous case was reported by a health care professional and describes the occurrence of MATERNAL EXPOSURE DURING BREAST FEEDING (Breastfeeding), DIZZINESS (Dizziness), HEADACHE (headache), FATIGUE (fatigue) and MYALGIA (muscle ache) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, the patient experienced MATERNAL EXPOSURE DURING BREAST FEEDING (Breastfeeding), DIZZINESS (Dizziness), HEADACHE (headache), FATIGUE (fatigue) and MYALGIA (muscle ache). On 29-Mar-2021, MATERNAL EXPOSURE DURING BREAST FEEDING (Breastfeeding) and DIZZINESS (Dizziness) had resolved. On 31-Mar-2021, HEADACHE (headache), FATIGUE (fatigue) and MYALGIA (muscle ache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not provided.  No treatment information was provided by reporter.   This case was linked to US-MODERNATX, INC.-MOD-2021-100823 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-100823:baby case
Sex: F
Vaccine: COVID19
Symptoms: Rhinorrhoea, Sneezing
Clinical narrative: developed a sneezing episode; nose would run; This spontaneous case was reported by a consumer and describes the occurrence of SNEEZING (developed a sneezing episode) and RHINORRHOEA (nose would run) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SNEEZING (developed a sneezing episode) and RHINORRHOEA (nose would run). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] at an unspecified dose and frequency. At the time of the report, SNEEZING (developed a sneezing episode) and RHINORRHOEA (nose would run) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication provided.   This case was linked to MOD-2021-101008 (Patient Link).
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Influenza like illness, Pyrexia, Vomiting
Clinical narrative: flu like symptoms; vomiting; chills; fever; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu like symptoms), VOMITING (vomiting), CHILLS (chills) and PYREXIA (fever) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028A21A and 012A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms), VOMITING (vomiting), CHILLS (chills) and PYREXIA (fever). At the time of the report, INFLUENZA LIKE ILLNESS (flu like symptoms), VOMITING (vomiting), CHILLS (chills) and PYREXIA (fever) outcome was unknown.            Concomitant medication was not provided. Treatment information was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-026841, US-MODERNATX, INC.-MOD-2021-026874 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-026841: US-MODERNATX, INC.-MOD-2021-026874:
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Bone pain, Chills, Headache, Pain in extremity
Clinical narrative: rash; SORE ARM; JOINT PAIN; CHILLS; COLD HANDS AND SHAKING VIOLENTLY; HEADACHE; sore arm; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 23-Apr-2021 and was forwarded to Moderna on 23-Apr-2021.    This spontaneous case was reported by a patient and describes the occurrence of RASH (rash), BONE PAIN (SORE ARM), ARTHRALGIA (JOINT PAIN), CHILLS (CHILLS) and TREMOR (COLD HANDS AND SHAKING VIOLENTLY) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included COPD, Food allergy (Wheat allergy), Food allergy (Barley allergy), Food allergy (Rye allergy) and Gluten intolerance.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage form. On an unknown date, the patient experienced RASH (rash), BONE PAIN (SORE ARM), ARTHRALGIA (JOINT PAIN), CHILLS (CHILLS), TREMOR (COLD HANDS AND SHAKING VIOLENTLY), HEADACHE (HEADACHE) and PAIN IN EXTREMITY (sore arm). At the time of the report, RASH (rash), BONE PAIN (SORE ARM), ARTHRALGIA (JOINT PAIN), CHILLS (CHILLS), TREMOR (COLD HANDS AND SHAKING VIOLENTLY), HEADACHE (HEADACHE) and PAIN IN EXTREMITY (sore arm) had resolved.            No concomitant medications provided. Treatment included Naproxen and antihistamines.    This case was linked to mod-2021-029396 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Rash, Tremor
Clinical narrative: rash; SORE ARM; JOINT PAIN; CHILLS; COLD HANDS AND SHAKING VIOLENTLY; HEADACHE; sore arm; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 23-Apr-2021 and was forwarded to Moderna on 23-Apr-2021.    This spontaneous case was reported by a patient and describes the occurrence of RASH (rash), BONE PAIN (SORE ARM), ARTHRALGIA (JOINT PAIN), CHILLS (CHILLS) and TREMOR (COLD HANDS AND SHAKING VIOLENTLY) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included COPD, Food allergy (Wheat allergy), Food allergy (Barley allergy), Food allergy (Rye allergy) and Gluten intolerance.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage form. On an unknown date, the patient experienced RASH (rash), BONE PAIN (SORE ARM), ARTHRALGIA (JOINT PAIN), CHILLS (CHILLS), TREMOR (COLD HANDS AND SHAKING VIOLENTLY), HEADACHE (HEADACHE) and PAIN IN EXTREMITY (sore arm). At the time of the report, RASH (rash), BONE PAIN (SORE ARM), ARTHRALGIA (JOINT PAIN), CHILLS (CHILLS), TREMOR (COLD HANDS AND SHAKING VIOLENTLY), HEADACHE (HEADACHE) and PAIN IN EXTREMITY (sore arm) had resolved.            No concomitant medications provided. Treatment included Naproxen and antihistamines.    This case was linked to mod-2021-029396 (Patient Link).
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue
Clinical narrative: mild chill; little fatigued; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (mild chill) and FATIGUE (little fatigued) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced CHILLS (mild chill) and FATIGUE (little fatigued). At the time of the report, CHILLS (mild chill) and FATIGUE (little fatigued) had resolved.            No relevant concomitant medications were reported. No treatment information was provided.    This case was linked to MOD-2021-003195 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 15-Jun-2021: Initial additional received on 15-JUN-2021, Updated outcome of all the 2nd dose events to recovered or resolved.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Acne, Erythema of eyelid, Eye pruritus, Eyelid margin crusting, Eyelid pain
Clinical narrative: Stye in right eye; Painful eyelid; swelling of eyelid; eyelid turned red; eyes are itchy; Tip of eyelid there was pus pimple; Scratchy; Drainage; Crustiness; headaches; This spontaneous case was reported by a consumer and describes the occurrence of HORDEOLUM (Stye in right eye), EYELID PAIN (Painful eyelid), SWELLING OF EYELID (swelling of eyelid), ERYTHEMA OF EYELID (eyelid turned red) and EYE PRURITUS (eyes are itchy) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001C21A and 045A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Stye and Surgery (Retinal surgery for retinal tears in the past in both eyes.).   On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 20-Apr-2021, the patient experienced HEADACHE (headaches). On 24-Apr-2021, the patient experienced HORDEOLUM (Stye in right eye), EYELID PAIN (Painful eyelid), SWELLING OF EYELID (swelling of eyelid), ERYTHEMA OF EYELID (eyelid turned red), EYE PRURITUS (eyes are itchy), ACNE (Tip of eyelid there was pus pimple), EYE PRURITUS (Scratchy), LACRIMATION INCREASED (Drainage) and EYELID MARGIN CRUSTING (Crustiness). At the time of the report, HORDEOLUM (Stye in right eye), EYELID PAIN (Painful eyelid), SWELLING OF EYELID (swelling of eyelid), ERYTHEMA OF EYELID (eyelid turned red), EYE PRURITUS (eyes are itchy), ACNE (Tip of eyelid there was pus pimple), EYE PRURITUS (Scratchy), LACRIMATION INCREASED (Drainage), EYELID MARGIN CRUSTING (Crustiness) and HEADACHE (headaches) outcome was unknown.            No concomitant medications were provided. Treatment reported includes  Warm compressions. She wears contacts and had retinal surgery for retinal tears in the past in both eyes.   This case was linked to MOD-2021-071890 (Patient Link).
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Hordeolum, Lacrimation increased, Swelling of eyelid
Clinical narrative: Stye in right eye; Painful eyelid; swelling of eyelid; eyelid turned red; eyes are itchy; Tip of eyelid there was pus pimple; Scratchy; Drainage; Crustiness; headaches; This spontaneous case was reported by a consumer and describes the occurrence of HORDEOLUM (Stye in right eye), EYELID PAIN (Painful eyelid), SWELLING OF EYELID (swelling of eyelid), ERYTHEMA OF EYELID (eyelid turned red) and EYE PRURITUS (eyes are itchy) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001C21A and 045A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Stye and Surgery (Retinal surgery for retinal tears in the past in both eyes.).   On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 20-Apr-2021, the patient experienced HEADACHE (headaches). On 24-Apr-2021, the patient experienced HORDEOLUM (Stye in right eye), EYELID PAIN (Painful eyelid), SWELLING OF EYELID (swelling of eyelid), ERYTHEMA OF EYELID (eyelid turned red), EYE PRURITUS (eyes are itchy), ACNE (Tip of eyelid there was pus pimple), EYE PRURITUS (Scratchy), LACRIMATION INCREASED (Drainage) and EYELID MARGIN CRUSTING (Crustiness). At the time of the report, HORDEOLUM (Stye in right eye), EYELID PAIN (Painful eyelid), SWELLING OF EYELID (swelling of eyelid), ERYTHEMA OF EYELID (eyelid turned red), EYE PRURITUS (eyes are itchy), ACNE (Tip of eyelid there was pus pimple), EYE PRURITUS (Scratchy), LACRIMATION INCREASED (Drainage), EYELID MARGIN CRUSTING (Crustiness) and HEADACHE (headaches) outcome was unknown.            No concomitant medications were provided. Treatment reported includes  Warm compressions. She wears contacts and had retinal surgery for retinal tears in the past in both eyes.   This case was linked to MOD-2021-071890 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Overdose, Product substitution error
Clinical narrative: patient receiving additional doses of the Moderna COVID-19 vaccine.; patient received "not real vaccines"; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health professional and describes the occurrence of OVERDOSE (patient receiving additional doses of the Moderna COVID-19 vaccine.) and PRODUCT SUBSTITUTION ERROR (patient received "not real vaccines") in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced OVERDOSE (patient receiving additional doses of the Moderna COVID-19 vaccine.) and PRODUCT SUBSTITUTION ERROR (patient received "not real vaccines"). At the time of the report, OVERDOSE (patient receiving additional doses of the Moderna COVID-19 vaccine.) and PRODUCT SUBSTITUTION ERROR (patient received "not real vaccines") had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medications were reported No treatment medications were reported
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Feeling hot, Headache
Clinical narrative: Dizziness, can't stand up because she falls; Very tired; Headache; Hotness; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Very tired), HEADACHE (Headache), FEELING HOT (Hotness) and DIZZINESS (Dizziness, can't stand up because she falls) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 009C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Apr-2021, the patient experienced FATIGUE (Very tired), HEADACHE (Headache) and FEELING HOT (Hotness). On 01-May-2021, the patient experienced DIZZINESS (Dizziness, can't stand up because she falls). On 30-Apr-2021, FATIGUE (Very tired), HEADACHE (Headache) and FEELING HOT (Hotness) had resolved. At the time of the report, DIZZINESS (Dizziness, can't stand up because she falls) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided. No treatment details were provided.
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: very achy; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (very achy) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (very achy). At the time of the report, PAIN (very achy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were reported No treatment medications were reported
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: vaccine recipient less than 18 yr old, first dose; This spontaneous case was reported by a physician and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (vaccine recipient less than 18 yr old, first dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039A21) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included LISDEXAMFETAMINE MESILATE (VYVANSE) for an unknown indication.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (vaccine recipient less than 18 yr old, first dose). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (vaccine recipient less than 18 yr old, first dose) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medications were reported
Sex: U
Vaccine: COVID19
Symptoms: Exposure via breast milk
Clinical narrative: Breastfeeding mother received vaccine; This spontaneous case was reported by a consumer and describes the occurrence of EXPOSURE VIA BREAST MILK (Breastfeeding mother received vaccine) in a  infant of an unknown age and gender exposed to mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002C21A) , while the mother received the product for COVID-19 vaccination.     No Medical History information was reported.    On 01-May-2021, the mother received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 01-May-2021, the infant was diagnosed with EXPOSURE VIA BREAST MILK (Breastfeeding mother received vaccine). At the time of the report, EXPOSURE VIA BREAST MILK (Breastfeeding mother received vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Transmammary) was unknown.       No concomitant medications reported.  No treatment information provided.
Sex: U
Vaccine: COVID19
Symptoms: Computerised tomogram, Lymphoedema, Peripheral swelling, Ultrasound Doppler, X-ray
Clinical narrative: Lymphedema; Arm began to swell/6 weeks later arm swelling was noticed/whole left arm was 1 inch thicker than right arm and hand/SWELLING MAY HAVE BEEN THERE BUT NOT NOTICED BY ME/SWELLING IS NOT PAINFUL/swelling remains 1 inch larger than right arm; This spontaneous case was reported by a physician and describes the occurrence of LYMPHOEDEMA (Lymphedema) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Renal insufficiency and Artificial cardiac pacemaker user.   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On an unknown date, the patient experienced LYMPHOEDEMA (Lymphedema) with PERIPHERAL SWELLING (Arm began to swell/6 weeks later arm swelling was noticed/whole left arm was 1 inch thicker than right arm and hand/SWELLING MAY HAVE BEEN THERE BUT NOT NOTICED BY ME/SWELLING IS NOT PAINFUL/swelling remains 1 inch larger than right arm). At the time of the report, LYMPHOEDEMA (Lymphedema) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Computerised tomogram: negative negative (Negative) Negative. On an unknown date, Ultrasound Doppler: negative negative (Negative) Arterial doppler study (Negative) and negative negative (Negative) Negative. On an unknown date, X-ray: negative negative (Negative) Negative.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient consulted pacemaker cardiologist and he said that he had occasionally seen arm swelling after insertion of pacemaker, though usually shortly after insertion.  Patient visited lymphedema clinic in MAY 2021 and have been managing lymphedema since. No concomitant medication details were reported. No treatment medication details was reported   This case was linked to MOD-2021-086256 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 02-Jun-2021: Follow-up received on 02JUN-2021.No new information added. On 04-Jun-2021: Follow up received on 04-JUN-2021.patient details and lad data updated. new events added.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: Slightly sore shoulder for 24-36 hours after each vaccine shot.; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Slightly sore shoulder for 24-36 hours after each vaccine shot.) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031B21A and 030A21A) for COVID-19 vaccination.     Concurrent medical conditions included Small lymphocytic lymphoma (Nodal marginal zone B-cell lymphoma) (Working Formulation) (SLL Cancer) since 2009, Bladder cancer since 2013, Arrhythmia since 2013, Hypertension since 2013, Arthritis since 2006, Penicillin allergy and Sulfonamide allergy (per unknown adverse reactions 1951). Concomitant products included DIGOXIN from 14-Dec-2016 to an unknown date, APIXABAN (ELIQUIS) from 02-Dec-2016 to an unknown date and METOPROLOL from 03-Dec-2016 to an unknown date for Arrhythmia cardiac (NOS), ATORVASTATIN from 20-Aug-2014 to an unknown date for Cholesterol, LATANOPROST from 09-Sep-2011 to an unknown date for Glaucoma, AMLODIPINE from 03-Jul-2013 to an unknown date, CHLORTHALIDONE from 24-Jun-2014 to an unknown date and LOSARTAN from 30-May-2013 to an unknown date for Hypertension, METHENAMINE from 10-Aug-2018 to an unknown date and TAMSULOSIN from 19-Aug-2018 to an unknown date for UTI, BPH and Urinary retention, MULTIVITAMINS;MINERALS for an unknown indication.   On 04-Mar-2021 at 10:17 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021 at 10:45 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Apr-2021, the patient experienced ARTHRALGIA (Slightly sore shoulder for 24-36 hours after each vaccine shot.). At the time of the report, ARTHRALGIA (Slightly sore shoulder for 24-36 hours after each vaccine shot.) had resolved.            New Verbatim term included patient called to provide updated information.  No treatment information provided.   This case was linked to MOD-2021-035803 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 13-Jul-2021: NNI FU
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Contusion, Headache, Pain, Rash erythematous
Clinical narrative: Bruise with a rash around it; rash with red bumps; Chills; Headache; Vaccination site pain; mild swelling; achiness; This spontaneous case was reported by a consumer and describes the occurrence of CONTUSION (Bruise with a rash around it), SWELLING (mild swelling), PAIN (achiness), RASH ERYTHEMATOUS (rash with red bumps) and CHILLS (Chills) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 28-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Apr-2021, the patient experienced SWELLING (mild swelling), PAIN (achiness), CHILLS (Chills), HEADACHE (Headache) and VACCINATION SITE PAIN (Vaccination site pain). On 01-May-2021, the patient experienced RASH ERYTHEMATOUS (rash with red bumps). On an unknown date, the patient experienced CONTUSION (Bruise with a rash around it). At the time of the report, CONTUSION (Bruise with a rash around it), SWELLING (mild swelling), PAIN (achiness), RASH ERYTHEMATOUS (rash with red bumps), CHILLS (Chills), HEADACHE (Headache) and VACCINATION SITE PAIN (Vaccination site pain) outcome was unknown.            Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 28-Jun-2021: Follow up received on 28-Jun-2021, No new information was added. On 22-Jul-2021: Follow up document received and contains significant information - New event Bruise  added.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling, Vaccination site pain
Clinical narrative: Bruise with a rash around it; rash with red bumps; Chills; Headache; Vaccination site pain; mild swelling; achiness; This spontaneous case was reported by a consumer and describes the occurrence of CONTUSION (Bruise with a rash around it), SWELLING (mild swelling), PAIN (achiness), RASH ERYTHEMATOUS (rash with red bumps) and CHILLS (Chills) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 28-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Apr-2021, the patient experienced SWELLING (mild swelling), PAIN (achiness), CHILLS (Chills), HEADACHE (Headache) and VACCINATION SITE PAIN (Vaccination site pain). On 01-May-2021, the patient experienced RASH ERYTHEMATOUS (rash with red bumps). On an unknown date, the patient experienced CONTUSION (Bruise with a rash around it). At the time of the report, CONTUSION (Bruise with a rash around it), SWELLING (mild swelling), PAIN (achiness), RASH ERYTHEMATOUS (rash with red bumps), CHILLS (Chills), HEADACHE (Headache) and VACCINATION SITE PAIN (Vaccination site pain) outcome was unknown.            Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 28-Jun-2021: Follow up received on 28-Jun-2021, No new information was added. On 22-Jul-2021: Follow up document received and contains significant information - New event Bruise  added.